Css LLC Aurinia Pharmaceuticals Inc. Call Options Transaction History

Css LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$6.66 - $12.39 $18,648 - $34,692	-2,800 Reduced 30.43%	6,400 $48,000
Q2 2022 Aug 15, 2022	SELL	$8.95 - $12.8 $13,424 - $19,200	-1,500 Reduced 14.02%	9,200 $92,000
Q1 2022 May 16, 2022	SELL	$10.05 - $22.48 $796,965 - $1.78 Million	-79,300 Reduced 88.11%	10,700 $132,000
Q4 2021 Feb 14, 2022	SELL	$17.78 - $33.08 $136,906 - $254,716	-7,700 Reduced 7.88%	90,000 $2.06 Million
Q3 2021 Nov 15, 2021	BUY	$10.93 - $23.55 $288,552 - $621,720	26,400 Added 37.03%	97,700 $2.16 Million
Q2 2021 Aug 16, 2021	SELL	$10.0 - $14.52 $65,000 - $94,380	-6,500 Reduced 8.35%	71,300 $924,000
Q1 2021 May 17, 2021	SELL	$12.3 - $18.73 $452,640 - $689,264	-36,800 Reduced 32.11%	77,800 $1.01 Million
Q4 2020 Feb 16, 2021	BUY	$12.94 - $16.05 $58,230 - $72,225	4,500 Added 4.09%	114,600 $1.59 Million
Q3 2020 Nov 16, 2020	BUY	$13.19 - $16.66 $296,775 - $374,850	22,500 Added 25.68%	110,100 $1.62 Million
Q2 2020 Aug 14, 2020	BUY	$14.12 - $18.33 $778,012 - $1.01 Million	55,100 Added 169.54%	87,600 $1.42 Million
Q1 2020 May 15, 2020	SELL	$11.34 - $21.46 $81,648 - $154,512	-7,200 Reduced 18.14%	32,500 $472,000
Q4 2019 Feb 14, 2020	BUY	$3.88 - $21.42 $154,036 - $850,374	39,700 New	39,700 $804,000

209

58.7M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.